Herpes simplex virus infections.
This review discusses current reports on herpes simplex virus infections as they relate to the use of laboratory testing, infections in the neonate, herpes simplex virus association with human immunodeficiency virus infection, and updating the current therapy and management of genital herpes. Findings over the past year are important in the clinical management of patients with genital herpes. All health care workers who manage patients with genital herpes need to know the limitations of serologic testing. Current information suggests that serologic commercial testing that is most commonly available cannot discriminate between infections caused by herpes simplex virus type 1 and type 2. Laboratory methods still rely on culturing herpes simplex virus in living cells in vitro. However, the availability of monoclonal antibodies allows for rapid assays for the confirmation of cultured herpes simplex virus. In addition, assays have been developed and tested, suggesting that perhaps antigen-detection systems may be available that could replace culturing the virus in living cells. New information on neonatal herpes points out the predictors of morbidity and mortality in newborns who contract herpes within the first few weeks of life. Information concerning asymptomatic shedding in labor will provide the clinician with a better understanding of this disease entity in the pregnant woman. Several studies have confirmed that herpes simplex virus infection is a risk factor for developing human immunodeficiency virus infection. A new study clearly shows that treatment using daily acyclovir therapy over a prolonged period of time can control and may modify herpesvirus infection.
Baker
D A
DA
Department of Obstetrics and Gynecology, State University of New York, Stony Brook 11794-8091.
D000212:Acyclovir / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D003937:Diagnosis, Differential; D004797:Enzyme-Linked Immunosorbent Assay / Q000592:standards; D005260:Female; D005455:Fluorescent Antibody Technique / Q000592:standards; D015658:HIV Infections / Q000150:complications; D015497:HIV-1; D006558:Herpes Genitalis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012680:Sensitivity and Specificity; D012703:Serotyping; D018139:Simplexvirus / Q000145:classification*; D015996:Survival Rate
D000212:Acyclovir